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(estimated glomerular filtration rate < 60 mllmin11.73 m2) although not ascribed to be a 
cause of dyspnea, occured in 50.0% of those with elevated BNP values) 500 pg/ml. 
Conclusion: Markedly elevated BNP values in the absense of CHF are rare. When they 
occur, they tend to reflect conditions increasing RV and LV wall tension with superim- 
posed volume overload due to chronic kidney disease. 
500 p.m. 
828FO-5 Myocardial Production of C-Type Natriuretic Peptide in 
Chronic Heart Failure 
Paul Ft. Kalra Jonathan Ft. Clague, Aidan P. Bolger, Philip A. Poole-Wilson, Allan D. 
Struthers, Andrew J. Coats, National Heart Lung Institute, London, United Kingdom, 
Clinical Pharmacology and Therapeutics, Dundee, United Kingdom 
Background: C-type natriuretic peptide (CNP) is a vasodilator produced by the vascular 
endothelium. It shares structural and physiological properties with the cardiac hormones 
atrial and brain natriuretic peptide (BNP). but little is known regarding its pathophysiolog- 
ical role in chronic heart failure (CHF). We assessed the hypothesis that CNP is pro- 
duced by the heart in patients with CHF. 
Methods: Myocardial CNP production was determined (difference in plasma levels 
between the aortic root and coronary sinus) in 9 patients undergoing right and left heart 
catheterisation as part of their CHF assessment (all male, age 59i9y; New York Heart 
Association class 2.2*0.1, LV ejection fraction 29*5%, mean&EM). BNP, established 
as originating from myocardium, was assessed from the same samples as a positive 
control. Analyses were performed using a standard competitive radioimmunoassay kit 
(Peninsula Laboratories, Bachem Ltd. UK). 
Results: A step-up (29%) in plasma CNP concentration was found from the aorta to the 
coronaty sinus (3.55i1.53 versus 4.59il.54 pg/mL, p=O.O35). The mean increase in 
CNP was 0.90+0.35 pg/mL (range 0.05 to 2.60 pg/mL). BNP levels increased by 57% 
from aorta to coronary sinus (66.0+20.5 versus 135.Oi42.2 pg/mL, p=O.Ol). Coronary 
sinus CNP levels correlated with mean pulmonary capillaty wedge pressure (r=O.62, 
p=O.O07). 
Conclusions: We have shown that CNP is produced by the heart in patients with chronic 
heart failure. Whilst fulther evaluation is required to define its full pathophysiological role 
in this condition, CNP may represent an important new local autocrine and/or endocrine 
mediator in the heart. 
5:15 p.m. 
828FO-6 Ventricular Endocrine and Wall Motion Function in 
Acute Myocardial Infarction 
lhab S. Ramzy, Christine A. O’Sullivan, Michael Kemp, James Hooper. Mark C. Dancy, 
Andrew J. Coats, Derek G. Gibson, Michael Y. Henein, Central Middlesex Hospital, 
London, United Kingdom, Royal Brompton Hospital, London, United Kingdom 
Aim: To investigate ventricular endocrine function in patients with coronary artery dis- 
ease during acute myocardial infarction (Ml). 
Methods: We studied 45 patients with acute Ml ; 13 anterior (age 57+ 12 years) and 32 
inferior (age 56+ 12 years). Atrial (ANP) and brain (BNP) natriuretic peptides were mea- 
sured on admission and on day 7 after thrombolysis. No patient was in heart failure, had 
additional valve disease or developed serious arrhythmia during the study period. 
Results: ANP increased from 13.7+ 12.7 on day one to 22.4* 14.0 pmol/L (NS) on day 7 
in anterior MI, and from 5.9* 4.6 to 16.2* 10.6 pmol/L (p<O.OOl) in inferior MI. BNP 
increased from 15.4r 26.1 to 61.7+ 54.3 pmol/L (~~0.02) in anterior Ml and from 6.5+ 
10.3 to 51.4i 52.4 pmollL (p<O.OOl) in Inferior Ml. ANP and BNP levels correlated with 
left free wall long axis excursion in anterior Ml (both r= -0.6, pcO.001). Whereas only BNP 
correlated with the anterior wall excursion in inferior Ml (r= -0.5, p<O.O05). There was no 
significant difference in peak CK level or fractional shortening between the two groups. 
Conclusion: Acute Ml is associated with a delayed rise in ANP and BNP in a pattern 
unrelated to the extent of myocardial damage. This rise is related to the severity of adja- 
cent segmental systolic dysfunction, thus suggesting either a compensatory mechanism 
for the myocardial loss or an ongoing remodeling process. 
ORAL CONTRIBUTIONS 
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830-1 Genetic Background Is a Major Determinant of 
Arteriogenesis After Femoral Artery Ligation in Inbred 
Mice 
Armin Helisch, Shawn Wagner, Ulrike Brandt, Matthias Heil. Tibor Ziegelhoeffer, Georg 
Bachmann, Wolfgang Schaper, Max-Planck-Institute for Physiol. & Clinical Research, 
Bad Nauheim, Germany. Kerckhoff-Klinik. Bad Nauheim, Germany 
Background: This study was performed to define the differences that may affect the 
recovery of the collateral-dependent hindtimb perfusion after arterial occlusion in inbred 
strains of mice. 
Methods: We ligated the right femoral artery (FA) of C57BU6 (n=l5) and BALB/c (n=l5) 
mice. PerfuSiOn was assessed by laser Doppler imaging (LDI) and calf blood flow by MRI 
(MRflow) on days 0, 3. 7, 14. and 28. MR angiography was performed in the 4” week. 
Furthermore, 8ALBlc and C57BU6 mice (n=5 per group) were fed with BrdU per drinking 
water starting one day prior to right FA ligation. After 7 days the left FA was also ligated 
and the animals were sacrificed. Postmoftem angiograms were performed utilizmg a bis- 
muth-gelatin contrast agent. Arrival of contrast in the left FA distal to the acute ligation 
site was timed and distal fillmg quantified by x-ray. BrdU stained cells were identified on 
cross-sections of adductor muscles. 
Results: BALB/c had more severe ischemia immediately after occlusion and the poorest 
recovery, as reflected by LDI and MR.inflow (p-zO.05, all timepoints). Distal collateral- 
dependent filling on postmortem angiography immediately after FA ligation was observed 
in 414 C57BU6 and O/5 BALBlc mice. Angiographically. similar patterns of preexistent 
and grown collateral vessels were identified in both strains, however, C57 mice tended to 
have better formed interarterial collateral connections in the quadriceps 4 weeks after FA 
ligation. In C57 mice, BrdU uptake during the first week after FA occlusion was seen in all 
layers of growing collateral arterioles and in infiltrating surrounding cells but not in capil- 
laries. Only in BALB/c capillary BrdU uptake was also observed in regions of focal pen- 
necrotic cellular infiltrates. The proliferation Index (BrdU positive cells/total vascular cells) 
in growing arterioles was higher in C57BU6 (0.67) than in BALBic (0.40, p < 0.05). 
Conclusion: Collateral artery growth in mouse hindlimbs of C57BU6 and BALE/c mice 
is independent of capillary proliferation. The improved recovery of C57BLi6 mice is asso- 
ciated with a better preformed collateral network. less acute ischemia, and an increased 
proliferation index in preexistent collateral arterioles. 
4:15 pm. 
830-2 The Early Growth Response-l (EGR-1) Gene Is Critical 
to Reperfusion Following Acute Vascular Obstruction: 
Results From a Knockout Mouse lschemia Model 
Paul Schalcb Ramaswamy Ramchandran, David Y. Kim, Gerald Patejunas, Mauricio A. 
Retuerto. Jeffrey D. Milbrandt, Ronald G. Crystal, Todd K. Rosengart, Evanston 
Northwestern Healthcare Research Institute. Evanston, IL, Weill Medical College of 
Cornell University, New York, NY 
Background: Angiogenesis induced by growth factor upregulation has been implicated as 
an Important biological response mechanism to acute vascular occlusion. The mecha- 
nism underlying this process is unclear, because tissues immediately surrounding vascu- 
lar occlusion sites that are the locus of collateral vessel formation are typically not 
ischemic. The early growth response-l gene (Egr-1) encodes for an immediate-early 
response transcription factor that is upregulated by changes in vascular strain, and which 
in turn upregulates the downstream expression of growth factors such as VEGF. We 
therefore hypothesize that Egr-1 may be an early messenger which translates post-liga- 
tion changes in vascular shear stress into growth factor upregulation and angiogenesis. 
Methods: A hind limb ischemia model consisting of proximal and distal ligation and exci- 
sion of the femoral artery was applied to 2-3 month old wild-type C57 BU6 mice @IO) or 
mice deficient in the Egr-1 gene (“knockout”, w5). Distal hind limb perfusion was serially 
assessed using laser Doppler perfusion imaging and expressed as an index of the mean 
perfusion in the ligated versus the non-ligated limb. 
Results: The pre-ischemic perfusion index for both the Egr-1 knockout and control mice 
was 1.00 * 0.03. Egr-1 knockout mice demonstrated a perfusion index immediately post- 
ligation of 0.15 f 0.02, compared to a post-ligation value of 0.23 * 0.02 in control animals 
(p = 0.006). All Egr-1 knockout mice developed necrosis of the ligated lamb between 1 
and 4 days after the procedure, but none of ,the control animals developed necrosis 
(p=O.OOl). The perfusion index failed to improve in knockout mice, while control mice 
demonstrated significant improvement from baseline in the perfusion Index at day 4 (0.32 
* 0.04, p = 0.01) and day 35 post-ligation (0.77 f 0.02, p=O.OOOl). 
Conclusion: Mice lacking expression of the Egr-1 gene exhibit a profound deficit in vas- 
cular collateralization and reperfusion following acute peripheral arterial occlusion. These 
findings suggest that Egr-1 plays a ptvotal role in vascular recovery in response to acute 
vascular occlusion, and could represent a potential target for therapeuttc intervention. 
4:30 p.m. 
830-3 Constitutive Overexpression of Hypoxia Inducible 
Factor-la/VP-l6 Enhances the In Vitro Angiogenicl 
Arteriogenic Effects of Mesenchymal Stromal Cells 
Tim D. Kinnaird Eugenio Stabile, Mary Susan Burnett, Yi Fu Zhou. Richard B&our. 
Cheol Whan Lee, Shmuel Fuchs, Stephen E. Epstein, Cardiovascular Research Institute, 
Washington, DC 
Background: We have recently demonstrated that mesenchymal stromal cells (MSCs) 
release a broad spectrum of angiogeniciarteriogenic cytokines and augment collateral 
response to ischemia. Constitutive over-expression of the hypoxia inducible factor-la/ 
VP-16 construct I” MSCs may enhance their therapeutic potential. Methods and Results: 
Murine MSCs were purified using double magnetic bead separation of cultured bone 
marrow. Flow cytometry confirmed absence of CD34, CD45, CD31 and CD1 17 surface 
markers, and the presence of SH2 and Sea-1 surface markers. MSCs were replated and 
transduced with Ad.HIF-laNPl6 vector, exposed to normoxia or 1% 02 for 24 hours and 
conditioned media (CM) collected. Using ELISA. CM VEGF and bFGF levels were 
increased following HIF-laNPl6 transduction (fig I); a cytokinelviral dose-dependant 
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response was obselved. Levels of MCP-1 and PIGF were unaffected by Ad.HIF-laNPl6 
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(VEGF) and monocyte chemoanractant protein-l (MCP-1) levels were measured by 
ELISA. The number of circulating endothelial progenitor cells (EPC) was determined by 
FACS analysis. Conclusion?.: SHS stimulates tumor growth, tumor angiogenesis, and the 
number of circulating endothelial progenitor cells. These effects were reduced by the nic- 
otinic receptor antagonist mecamylamine Indicating an important role for nicotine; and 
were reduced by cerivastatin which together with reduced MCP-1 levels suggests a 
strong anti-inflammatory effect. 
2000 
transduction. CM was added to endothelial (EC) and smooth muscle (SMC) cell cultures 
to a?sess proliferation. When compared to CM from MSC’s under normoxia or hypoxia, 
CM from transduced MSCs increased EC (290% vs 31% vs 79% compared to control 
media, p<O.OOl) and SMC (220% vs 26% vs 56%, p<O.OOl) proliferation. CM from trans- 
duced cells enhanced tube formation on Matrigel plates compared to control or MSC 
media. Conclusion?.: Constitutive over-expression of HIF-la/VP-l6 augments In-vitro 
angiogeniclarteriogenic effects of MSCs and may represent a novel approach for thera- 
peutic angiogenesis. 
4:45 p.m. 
830-4 MCP-1 Induces a Sustained Arteriogenic Response in 
ApoE Mice but Accelerates Atherosclerotic Plaque 
Development 
Niels van Roven, Imo Hoefer. Markus Boeninger, Jing Hua, Sebastian Grundmann, 
Mlchiel Voskuil. Christooh Bode. Wolfaano Schaoer. Ivo R. Buscchmann. Jan J. Piek. 
Academic Med/cal Cenier, University of A&terd& Amsterdam, The Netherlands, 
University of Freiburg, Freiburg, Germany 
Introduction: Monocyte Chemoanractant Protein-l (MCP-1) increases the formation of a 
collateral circulation upon arterial occlusion. The present study served to determlne 
whether these pro-arteriogenic properties of MCP-1 are preserved in hyperlipidemic 
ApoE -I- mice and whether it affects systemic development of atherosclerosis. 
Methods: 72 ApoE -/- mice were treated with low dose MCP-1 (1 pS/kg/week), high dose 
MCP-1 (10 pg/kg/week) or Phosphate Buffered Saline (PBS) as control after unilateral 
ligation of the femoral artery. Collateral flow was measured using fluorescent micro- 
spheres. In addition, monocytic Cdllb expression was measured by FACS-analysis. 
The number of adhering monocytes. neointlma formation and cellular plaque composi- 
tion were determined histologically. Total plaque surface was quantified after Sudan IV 
taining. 
Results: Collateral hindlimb flow significantly increased upon high dose MCP-1 treatment 
(PBS: 22.6% * 7.2%, MCP-1: 31.3% f 10.3%, pcO.05). These effects were still present 
two months after the treatment (PBS: 44.3% * 4.6%, MCP-1: 56.5% * 10.4%. pcO.001). 
However, an increase was observed for systemic CD1 1 b expression by monocytes. 
monocyte adhesion at the aortic endothelium and neointima formation (PBS: 0.097 * 
0.011 vs. MCP-1: 0.257 * 0.022, intimafmedia ratio, p<O.OOOl). Moreover an IncreaSe in 
aortic atherosclerotic plaque surface was observed (PBS: 24.3% * 5.2% vs. MCP-1: 
36.2% * 9.5%, p<O.Ol) as well as a significant decrease in the percentage of smooth 
muscle cells (control: 15.0% + 5.2% vs. 5.6% * 2.3%, p<O.OOOl). 
Conclusion: Local infusion of MCP-1 significantly increases collateral flow upon femoral 
artery legation in ApoE -/- mice up to two months after the treatment. The local treatment 
however did not preclude systemic effects on atherogenesis. showng an increase in 
monocyte adehesion to aortic endothelium as well as increased neointima formation. 
Moreover, the local MCP-1 treatment induced changes in cellular content of plaques. 
5:00 p.m. 
830-5 Exposure to Second Hand Smoke Stimulates 
Angiogenesis in Tumors 
Boaina Zhu, Christopher Heeschen, Richard E. Sievers. Stanton A. Glantz, Kanu 
Chanerjee, William W. Parsley, John P. Cooke, University of California San Francisco, 
San Francisco, CA, Stanford University, Stanford, CA 
Background: Exposure to second hand smoke (SHS) Increases the incidence of athero- 
sclerosis, cardiovascular death, and lung cancer. Pathological angiogenesis plays a role 
!n the growth of atheroma and tumor. Methods: To investigate the effects of SHS on 
angiogenesis we used a murine Lews lung cancer model. SHS groups were exposed to 
SHS (4 cigarettes/l5 men, 6 hours/day). Non-SHS groups were exposed to fresh air. 
Mice were randomized (n=6, each group): two non-SHS groups (control and cerivastatln 
[2.5 mglkg, HMG-CoA reductase Inhibitor]) and three SHS groups (control, cerivastatin, 
and mecamylamine IO.5 g/kg. nicotinic acetylchollne receptor antagonist]). After 6 days, 
all mice were sacrificed due to excesswe tumor growth in the control arm of the SHS 
group. Tumor size was determined with a digltal c&per. Angiogenesis was determined 
by infusion of space-filling fluorescent mlcrospheres. Vascular endothelial growth factor 
Treatment 
Tumor size (cm) 
Tumor weight (g) 
Capillaries/mm2 
VEGF (pg/ml) 
MCP-1 (no/ml) 
EPC (%) 
:sults (* PC0 01 as compared with Non-SHS control group) 
Non-SHS Non-SHS SHS SHS SHS 
Control Cerivastatin Control Cenvastatin Mecamylamine 
0.25*0.0 0.17ztO.04 1.31*0.44’ 0.59*0.14’ 0.66+0.29’ 
5 
0.17*0.0 0.11+0.03 0.93*0.27’ 0.35*0.13’ 0 34+0.12’ 
4 
4.6k1.9 3.9il.4 6.5t2.3 5.6i1.6 4.9*2.3 
50*16 39*9 139+23 121*16 73*29 
5.9ztl.2 4.6t0.6 14.2zt2.5’ 6.9+1.6 12.1+2.3’ 
l.OiO.2 1.3*0.3 3.9*0.4* 2.6+0.4’ 2.1+0.4’ 
5:15 p.m. 
830-6 Vascular Endothelial Growth Factor Induces Both 
Angiogenesis and Arteriogenesis Independently of 
Nitric Oxide 
Timothv J. Chico, Joan Grew, Hope Steinmetz. John Hoeflel, Ann Daugherty, Simon P. 
Williams, Stuart Bunting, Nicholas Van Bruggen, Genentech Inc., South San Francisco, 
CA 
Background. Vascular Endothelial Growth Factor (VEGF) is a potent angiogenic factor, 
though its effect on larger vessels (arteriogenesis) is unclear. Nitric oxide (NO) is sug- 
gested to mediate the effects of VEGF. We therefore evaluated the effect of exogenous 
VEGF on angiogenesis, arteriogenesis, and tissue perfusion with and without NO syn- 
thase inhibition. 
Methods. 8-12 week old male C57 mice were treated chronically with oral L-NAME (a 
NO synthase inhibltor) or control from one week before until the end of the study. Mice 
were injected into the left calf with murine VEGF or vehicle 7d after starting L-NAMElcon- 
trol. Arteriogenesis was assessed using Magnetic Resonance Angiography (MRA) 1, 3 
and 5 days after injection. AnglogenesIs was assessed 7d after injection by histology and 
radiolabelled anti-PECAM binding. Regional blood flow to the calf was measured using 
radiolabeled microsphere deposition either in the resting state or after 1Om1n electrical 
sciatic nerve stimulation (4V 8 4Hz) to simulate exercise-induced flow recruitment. Sta- 
tistical comparisons were by ANOVA. 
Results. Followlna VEGF treatment an increase in caoillarv densitv was observed hIsto- ._ , 
logically. Calf endothelral cell density was increased by 166% compared to control 
1~~0.051. MRA revealed a time-deoendent increase in anaioaraohicallv detectable ves- ,, 1 1 1  _  
sels proximal to the Injected region. VEGF increased both resting calf blood flow (129+20 
vews 13*2 ml/min1100g, ~~0.05) and calf blood flow after sciatic nerve stimulation 
(167+21 versus 80+29 ml/mln/lOOg, ~~0.05). These increases were confined to the 
region injected and were not seen in the thigh or foot. Chronic L-NAME treatment had no 
effect on either endothelial cell density or the angiographic appearance of vehicle and 
VEGF treated groups. The VEGF-induced increase in resting blood flow was, however 
completely abolished by L-NAME (1913 ml/min/lOOg). 
Conclusions. Exogenous VEGF increases both anglogenesIs and the size of larger ves- 
sels supplying the injected region. While NO mediates the increase I” blood flow associ- 
ated with these changes, the effects of VEGF on vascular remodelling at both the 
capillary and arterial level do not require intact NOS. 
ORAL CONTRIBUTIONS 
832 Hypertensive Heart Disease and 
Endothelial Function: Diagnosis and 
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Monday, March 31, 2003,4:00 p.m.-530 p.m. 
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4:00 p.m. 
832-1 Sildenafil Improves Endothelial Dysfunction in Treated 
Hypertensive Heart Transplant Recipients 
Juan Estrada. Rahul Aggawal, David G. Edwards, Brian T. Schuler, Richard S. 
Schofield, Juan M. Aranda. Jr., James A. Hill, Wilmer W. Nichols, University of Florida, 
Gainesville, FL 
Background: Flow-mediated dilation (FMD) during reactive hyperemia is an Index of 
nitric oxide (NO) dependent endothelial function and is reduced in heart transplant recip- 
ients. NO reduction IS associated wth decreased production of cyclic guanosine mono- 
phosphate (cGMP). Sildenafil. a type 5 phosphodiesterase Inhibitor. may enhance the 
production of cGMP, increase the release of NO and improve endothelial dysfunction. 
Accordingly, the aim of this study was to determine the effects of sildenafil on brachial 
